Prof. Nicolas LANTHIER - Pôle d'Hépato-gastro-entérologie (GAEN), UCLouvain & Cliniques Universitaires Saint-Luc

Metabolic steatohepatitis, gut microbiota and skeletal muscle changes: three pieces of the same risky puzzle? From results to new projects

Related publications:

• Lanthier, N. et al. Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Nature 659 (2021). doi: 10.1038/s41598-020-79718-9
• Henin, G. et al. Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease. JHEP REP 2023 Nov 14;6(2):100963. doi: 10.1016/j.jhepr.2023.100963
• Henin, G., Lanthier N. What references and what gold standard should be used to assess myosteatosis in chronic liver disease? J Hepato, 2024 Dec;81(6):e273-e274. doi: 10.1016/j.jhep.2024.07.003 
• Harrison SA et al. A Randomized Controlled Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. New England Journal of Medicine, 2024, 390/6, pages 497-509. doi: 10.1056/NEJMoa2309000
• Guillaume Henin et al. Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease? Liver Int. 2024 Aug;44(8):1781-1796. doi: 10.1111/liv.15938

Info: laure.bindels@uclouvain.be